{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:40:12Z","timestamp":1758577212856,"version":"3.44.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.taap.2023.116471","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T15:55:15Z","timestamp":1679068515000},"page":"116471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pathophysiology and human cancer risk assessment of pharmaceutical-induced thymoma in carcinogenicity studies"],"prefix":"10.1016","volume":"466","author":[{"given":"Zaher A.","family":"Radi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasir","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2023.116471_bb0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev-immunol-051116-052320","article-title":"Thymic epithelial cells","volume":"35","author":"Abramson","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.taap.2023.116471_bb0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lungcan.2018.10.018","article-title":"Systemic treatments for thymoma and thymic carcinoma: a systematic review","volume":"126","author":"Berghmans","year":"2018","journal-title":"Lung Cancer"},{"issue":"7","key":"10.1016\/j.taap.2023.116471_bb0015","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/0192623316660768","article-title":"Findings in historical control Harlan RCCHan\u2122: WIST rats from 104-week oral gavage studies","volume":"44","author":"Blankenship","year":"2016","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.taap.2023.116471_bb0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mrrev.2010.02.004","article-title":"Genotoxicity and carcinogenicity testing of pharmaceuticals: correlations between induction of DNA lesions and carcinogenic activity","volume":"705","author":"Brambilla","year":"2010","journal-title":"Mutat. Res."},{"key":"10.1016\/j.taap.2023.116471_bb0025","first-page":"560","article-title":"The most appropriate strain for rat carcinogenicity bioassay","volume":"78","author":"Britton","year":"2004","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.taap.2023.116471_bb0030","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/1091581810374654","article-title":"Critical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia","volume":"29","author":"Bugelski","year":"2010","journal-title":"Int. J. Toxicol."},{"issue":"5","key":"10.1016\/j.taap.2023.116471_bb0035","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood.V97.5.1336","article-title":"Dissociation of thymic positive and negative selection in transgenic mice expressing major histocompatibility complex class I molecules exclusively on thymic cortical epithelial cells","volume":"97","author":"Capone","year":"2001","journal-title":"Blood."},{"key":"10.1016\/j.taap.2023.116471_bb0045","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.yrtph.2017.11.020","article-title":"Carcinogenicity assessment of baricitinib in Tg. rasH2 mice and Sprague-Dawley (Crl: CD) rats","volume":"92","author":"Carfagna","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2023.116471_bb0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.yrtph.2019.01.017","article-title":"Chemical carcinogenicity revisited 3: risk assessment of carcinogenic potential based on the current state of knowledge of carcinogenesis in humans","volume":"103","author":"Cohen","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"author":"Delgocitinib","key":"10.1016\/j.taap.2023.116471_bb0055"},{"issue":"6","key":"10.1016\/j.taap.2023.116471_bb0060","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/jemt.10408","article-title":"Evolution of the thymus size in response to physiological and random events throughout life","volume":"62","author":"Dom\u00ednguez-Gerpe","year":"2003","journal-title":"Microsc. Res. Tech."},{"issue":"5","key":"10.1016\/j.taap.2023.116471_bb0065","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.4049\/jimmunol.1302961","article-title":"Adult thymic epithelium contains nonsenescent label-retaining cells","volume":"192","author":"Dumont-Lagac\u00e9","year":"2014","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.taap.2023.116471_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep12895","article-title":"Sex hormones have pervasive effects on thymic epithelial cells","volume":"5","author":"Dumont-Lagac\u00e9","year":"2015","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.taap.2023.116471_bb0075","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of thymoma and associated malignancies","volume":"5","author":"Engels","year":"2010","journal-title":"J. Thorac. Oncol."},{"year":"2001","series-title":"Statistical Aspects of the Design, Analysis, and Interpretation of Chronic Rodent Carcinogenicity Studies of Pharmaceuticals","author":"Food and Drug Administration Draft Guidance for Industry","key":"10.1016\/j.taap.2023.116471_bb0080"},{"issue":"2","key":"10.1016\/j.taap.2023.116471_bb0085","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/019262338401200203","article-title":"Use of historical control data in carcinogenicity studies in rodents","volume":"12","author":"Haseman","year":"1984","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.taap.2023.116471_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2131\/jts.47.1","article-title":"Development challenges for carcinogenicity risk assessments of topical drugs","volume":"47","author":"Hollingshead","year":"2022","journal-title":"J. Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.taap.2023.116471_bb0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1349-7006.2003.tb01343.x","article-title":"A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals","volume":"94","author":"Ito","year":"2003","journal-title":"Cancer Sci."},{"key":"10.1016\/j.taap.2023.116471_bb0100","series-title":"The 29th Annual Meeting of the Japanese Society of Toxicologic Pathology. Poster 39 Abstract","first-page":"83","article-title":"Spontaneous thymoma observed in Wistar Han rats","author":"Iwata","year":"2013"},{"issue":"5","key":"10.1016\/j.taap.2023.116471_bb0105","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/0192623314566241","article-title":"Regulatory forum opinion piece. Transgenic\/alternative carcinogenicity assays: a retrospective review of studies submitted to CDER\/FDA 1997\u20132014","volume":"43","author":"Jacobs","year":"2015","journal-title":"Toxicol. Pathol."},{"issue":"4","key":"10.1016\/j.taap.2023.116471_bb0110","first-page":"359","article-title":"International regulatory needs for development of an IATA for non-genotoxic carcinogenic chemical substances","volume":"33","author":"Jacobs","year":"2016","journal-title":"ALTEX"},{"key":"10.1016\/j.taap.2023.116471_bb0115","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1007\/s00204-020-02784-5","article-title":"Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens","volume":"94","author":"Jacobs","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"5","key":"10.1016\/j.taap.2023.116471_bb0120","doi-asserted-by":"crossref","first-page":"851S","DOI":"10.1093\/jn\/127.5.851S","article-title":"The effects of diet, overfeeding and moderate dietary restriction on Sprague-Dawley rat survival, disease and toxicology","volume":"127","author":"Keenan","year":"1997","journal-title":"J. Nutr."},{"issue":"1","key":"10.1016\/j.taap.2023.116471_bb0125","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/jcp.56.1.12","article-title":"What is Good\u2019s syndrome? Immunological abnormalities in patients with thymoma","volume":"56","author":"Kelleher","year":"2003","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.taap.2023.116471_bb0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejcts.2005.03.039","article-title":"Myasthenia gravis appearing after thymectomy for thymoma","volume":"28","author":"Kondo","year":"2005","journal-title":"Eur. J. Cardiothorac. Surg."},{"author":"Leflunomide. Food and Drug Administration (FDA)","key":"10.1016\/j.taap.2023.116471_bb0135"},{"key":"10.1016\/j.taap.2023.116471_bb0140","series-title":"Biopharmaceutical Applied Statistics Symposium. 2018. ICSA Book Series in Statistics","article-title":"Expanded statistical decision rules for interpretations of results of rodent carcinogenicity studies of pharmaceuticals","author":"Lin","year":"2018"},{"key":"10.1016\/j.taap.2023.116471_bb0145","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nature13317","article-title":"Cell competition is a tumour suppressor mechanism in the thymus","volume":"509","author":"Martins","year":"2014","journal-title":"Nature."},{"issue":"7","key":"10.1016\/j.taap.2023.116471_bb0150","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1177\/0192623319863119","article-title":"Comparative incidences and biological outcomes for Thymoma in various rat strains in national toxicology program studies","volume":"47","author":"Moore","year":"2019","journal-title":"Toxicol. Pathol."},{"issue":"5","key":"10.1016\/j.taap.2023.116471_bb0155","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/0192623313502130","article-title":"Regulatory forum commentary: alternative mouse models for future cancer risk assessment","volume":"42","author":"Morton","year":"2014","journal-title":"Toxicol. Pathol."},{"issue":"5","key":"10.1016\/j.taap.2023.116471_bb0160","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/00001622-200009000-00007","article-title":"Thymoma","volume":"12","author":"M\u00fcller-Hermelink","year":"2000","journal-title":"Curr. Opin. Oncol."},{"author":"Mycophenolic Acid. Food and Drug Administration (FDA)","key":"10.1016\/j.taap.2023.116471_bb0165"},{"issue":"1","key":"10.1016\/j.taap.2023.116471_bb0170","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.onc.1203266","article-title":"Heritable lympho-epithelial thymoma resulting from a transgene insertional mutation","volume":"19","author":"Nakajima","year":"2000","journal-title":"Oncogene."},{"issue":"2","key":"10.1016\/j.taap.2023.116471_bb0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/096032719301200201","article-title":"Fat, frail and dying young: survival, body weight and pathology of the Charles River Sprague-Dawley-derived rat prior to and since the introduction of the VAFR variant in 1988","volume":"12","author":"Nohynek","year":"1993","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.taap.2023.116471_bib246","unstructured":"Olumiant\u00ae (baricitinib) U.S. Prescribing Information, 2018. Accessed electronically on 17 March 2023 at: www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/207924s006lbl.pdf."},{"issue":"3","key":"10.1016\/j.taap.2023.116471_bb0180","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1210\/endo.142.3.8032","article-title":"Androgen receptors in thymic epithelium modulate thymus size and thymocyte development","volume":"142","author":"Olsen","year":"2001","journal-title":"Endocrinology."},{"key":"10.1016\/j.taap.2023.116471_bb0185","article-title":"Pharmaceuticals and medical devices agency (PMDA)","author":"Peficitinib.","year":"2019","journal-title":"Pharmacol. Rev."},{"author":"Pimecrolimus. Food and Drug Administration (FDA)","key":"10.1016\/j.taap.2023.116471_bb0190"},{"key":"10.1016\/j.taap.2023.116471_bib247","unstructured":"Rinvoq\u00ae (upadacitinib) Summary of Product Characteristics, 2019. Accessed electronically on 17 March 2023 at: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/olumiant-epar-product-information_en.pdf."},{"issue":"2","key":"10.1016\/j.taap.2023.116471_bb0195","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1074-7613(01)00180-7","article-title":"Stat3 in thymic epithelial cells is essential for postnatal maintenance of thymic architecture and thymocyte survival","volume":"15","author":"Sano","year":"2001","journal-title":"Immunity."},{"issue":"4","key":"10.1016\/j.taap.2023.116471_bb0200","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1177\/0192623311406935","article-title":"An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelines","volume":"39","author":"Sistare","year":"2011","journal-title":"Toxicol. Pathol."},{"issue":"5","key":"10.1016\/j.taap.2023.116471_bb0205","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-3083.1985.tb01916.x","article-title":"The involution of the ageing human thymic epithelium is independent of puberty: a morphometric study","volume":"22","author":"Steinmann","year":"1985","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.taap.2023.116471_bb0210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1293\/tox.2020-0005","article-title":"Comparison of longevity and common tumor profiles between Sprague-Dawley and Han Wistar rats","volume":"33","author":"Taylor","year":"2020","journal-title":"J. Toxicol. Pathol."},{"issue":"2","key":"10.1016\/j.taap.2023.116471_bb0215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/0192623318822301","article-title":"Thymomas and associated hyperplastic lesions in Wistar Hannover rats","volume":"47","author":"Tomonari","year":"2019","journal-title":"Toxicol. Pathol."},{"author":"US FDA, Center for Drug Evaluation and Research","key":"10.1016\/j.taap.2023.116471_bb0225"},{"author":"US FDA, Center for Drug Evaluation and Research","key":"10.1016\/j.taap.2023.116471_bb0230"},{"issue":"1","key":"10.1016\/j.taap.2023.116471_bb0235","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1177\/0192623316672075","article-title":"Differences in types and incidence of neoplasms in Wistar Han and Sprague-Dawley rats","volume":"45","author":"Weber","year":"2017","journal-title":"Toxicol. Pathol."},{"issue":"6","key":"10.1016\/j.taap.2023.116471_bb0240","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1177\/0192623319867053","article-title":"Nonproliferative and proliferative lesions of the rat and mouse hematolymphoid system","volume":"47","author":"Willard-Mack","year":"2019","journal-title":"Toxicol. Pathol."},{"author":"Xeljanz\u00ae (tofacitinib) Summary of Product Characteristics","key":"10.1016\/j.taap.2023.116471_bb0245"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X23001096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X23001096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:01:45Z","timestamp":1758574905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X23001096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":49,"alternative-id":["S0041008X23001096"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2023.116471","relation":{},"ISSN":["0041-008X"],"issn-type":[{"type":"print","value":"0041-008X"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiology and human cancer risk assessment of pharmaceutical-induced thymoma in carcinogenicity studies","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2023.116471","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116471"}}